Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Conditioning Regimens

Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy

Bone Marrow Transplantation volume 29, pages 949–956 (2002)Cite this article

Abstract

Hematopoietic macrochimerism, established by bone marrow transplantation, can be used as an approach for treating autoimmune disease and inducing transplant tolerance. In this study, we investigated whether a stable, high level of fully MHC-mismatched hematopoietic macrochimerism can be induced by using irradiation-free protocols, and whether rapamycin and T cell costimulatory blockades (anti-CD40L monoclonal antibody (mAb) and CTLA4Ig) as post-transplant treatment promote bone marrow engraftment. Donor-specific blood transfusion (DST), anti-lymphocyte serum (ALS), busulfan, and cyclophosphamide were given pretransplantation. Balb/c (H-2d) bone marrow cells, at a dose of 4 × 107, were infused into each C57BL/6 mouse (H-2b). Rapamycin, anti-CD40L mAb, and CTLA4Ig were then administered, either alone or in combination. Without ALS or busulfan and cyclophosphamide, macrochimerism can only rarely be induced. Donor-specific transfusion (DST) enhances induction of hematopoietic macrochimerism. Rapamycin, anti-CD40L mAb and CTLA4Ig, alone or in combination, induce a stable and high level of hematopoietic macrochimerism. In the chimeric mice, donor-derived cells were detected in all lymphohematopoietic tissues and donor-specific tolerance was induced in vitro. We conclude that a stable and high level of fully MHC-mismatched hematopoietic macrochimerism can be induced in mice after transplanting a single modest dose of bone marrow cells without irradiation. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote bone marrow engraftment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Ildstad ST, Sachs DH . Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts Nature 1984 307: 168 170

    Article  CAS  Google Scholar 

  2. Cobbold SP, Martin G, Qin S, Waldmann H . Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance Nature 1986 323: 164 166

    Article  CAS  Google Scholar 

  3. Wekerle T, Sykes M . Mixed chimerism as an approach for the induction of transplantation tolerance Transplantation 1999 68: 459 467

    Article  CAS  Google Scholar 

  4. Sachs DH . Mixed chimerism as an approach to transplantation tolerance Clin Immunol 2000 95: S63 S68

    Article  CAS  Google Scholar 

  5. Wekerle T, Kurtz J, Ito H et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment Nat Med 2000 6: 464 469

    Article  CAS  Google Scholar 

  6. Durham MM, Bingaman AW, Adams AB et al. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning J Immunol 2000 165: 1 4

    Article  CAS  Google Scholar 

  7. Hale DA, Gottschalk R, Umemura A et al. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation Transplantation 2000 69: 1242 1251

    Article  CAS  Google Scholar 

  8. Tomita Y, Sachs DH, Sykes M . Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow Blood 1994 83: 939 948

    CAS  PubMed  Google Scholar 

  9. Tomita Y, Yoshikawa M, Zhang QW et al. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide J Immunol 2000 165: 34 41

    Article  CAS  Google Scholar 

  10. Guo Z, Wu T, Kirchhof N et al. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection Transplantation 2001 71: 1656 1665

    Article  CAS  Google Scholar 

  11. Matesic D, Lehmann PV, Heeger PS . High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice Transplantation 1998 65: 906 914

    Article  CAS  Google Scholar 

  12. Acha-Orbea H, Palmer E . Mls – a retrovirus exploits the immune system (see comments) Immunol Today 1991 12: 356 361

    Article  CAS  Google Scholar 

  13. Dyson PJ, Knight AM, Fairchild S et al. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes (see comments) Nature 1991 349: 531 532

    Article  CAS  Google Scholar 

  14. Sykes M, Szot GL, Swenson KA, Pearson DA . Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning Nat Med 1997 3: 783 787

    Article  CAS  Google Scholar 

  15. Wekerle T, Sayegh MH, Hill J et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance J Exp Med 1998 187: 2037 2044

    Article  CAS  Google Scholar 

  16. Mayumi H, Himeno K, Tanaka K et al. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients Transplantation 1986 42: 417 422

    Article  CAS  Google Scholar 

  17. Eto M, Mayumi H, Tomita Y et al. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens J Exp Med 1990 171: 97 113

    Article  CAS  Google Scholar 

  18. Tomita Y, Nishimura Y, Harada N et al. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion J Immunol 1990 145: 4026 4036

    CAS  PubMed  Google Scholar 

  19. Adams AB, Durham MM, Kean L et al. Costimulation blockade, busulfan, and bone marrow promote titratable marochimerism, induce transplantation tolerance and correct genetic hemoglobinopathies with minimal myelosuppression J Immunol 2001 167: 1103 1111

    Article  CAS  Google Scholar 

  20. Sehgal SN . Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression Clin Biochem 1998 31: 335 340

    Article  CAS  Google Scholar 

  21. Blazar BR, Taylor PA, Snover DC et al. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome J Immunol 1993 151: 5726 5741

    CAS  PubMed  Google Scholar 

  22. Blazar BR, Taylor PA, Sehgal SN, Vallera DA . Rapamycin prolongs survival of murine recipients of fully allogeneic donor grafts when administered during the graft-versus-host disease process Ann NY Acad Sci 1993 685: 73 85

    Article  CAS  Google Scholar 

  23. Chen BJ, Morris RE, Chao NJ . Graft-versus-host disease prevention by rapamycin: cellular mechanisms Biol Blood Marrow Transplant 2000 6: 529 536

    Article  CAS  Google Scholar 

  24. Abraham RT, Wiederrecht GJ . Immunopharmacology of rapamycin Annu Rev Immunol 1996 14: 483 510

    Article  CAS  Google Scholar 

  25. Bierer BE, Mattila PS, Standaert RF et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin Proc Natl Acad Sci USA 1990 87: 9231 9235

    Article  CAS  Google Scholar 

  26. Li Y, Li XC, Zheng XX et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance Nat Med 1999 5: 1298 1302

    Article  CAS  Google Scholar 

  27. Wells AD, Gudmundsdottir H, Turka LA . Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response J Clin Invest 1997 100: 3173 3183

    Article  CAS  Google Scholar 

  28. Li Y, Zheng XX, Li XC et al. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment Transplantation 1998 66: 1387 1388

    Article  CAS  Google Scholar 

  29. Quesenberry PJ, Zhong S, Wang H, Stewart M . Allogeneic chimerism with low-dose irradiation, antigen presentation, and costimulator blockade in H-2 mismatch mice Blood 2001 98: 557 564

    Article  Google Scholar 

  30. Taylor PA, Lees CJ, Waldmann H et al. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyelablative conditions Blood 2001 98: 467 474

    Article  CAS  Google Scholar 

  31. Sykes M, Bukhari Z, Sachs DH . Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation Bone Marrow Transplant 1989 4: 465 474

    CAS  PubMed  Google Scholar 

  32. Tomita Y, Khan A, Sykes M . Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen J Immunol 1994 153: 1087 1098

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partly supported by grants awarded by the Juvenile Diabetes Foundation International and by the American Diabetes Association.

Author information

Author notes

  1. T Wu

    Present address: Department of Surgery, First Hospital of Beijing University, Beijing, China

  2. P Lan

    Present address: Bone Marrow Transplantation Section, Transplantation Biology Research Center, Massachusetts General Hospital/ Harvard Medical School, Boston, 02129, MA, USA

Authors and Affiliations

  1. Diabetes Institute for Immunology and Transplantation, and Department of Surgery, University of Minnesota, Minneapolis, MN, USA

    T Wu, H Sozen, B Luo, N Heuss, H Kalscheuer, P Lan, DER Sutherland, BJ Hering & Z Guo

Authors
  1. T Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Sozen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Heuss
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Kalscheuer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. DER Sutherland
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. BJ Hering
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Z Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, T., Sozen, H., Luo, B. et al. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy. Bone Marrow Transplant 29, 949–956 (2002). https://doi.org/10.1038/sj.bmt.1703574

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703574

Keywords

Search

Advanced search

Quick links